AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.52
-0.05 (-1.95%)
At close: Aug 15, 2025, 3:58 PM
2.65
5.16%
After-hours: Aug 15, 2025, 07:30 PM EDT

AIM ImmunoTech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.32M -28.96M -19.45M -19.13M
Depreciation & Amortization
246K 238K 256K 805K
Stock-Based Compensation
686K 243K 954K 1.57M
Other Working Capital
-828K 573K 787K 1.05M
Other Non-Cash Items
1.2M 310K 964K 4.24M
Deferred Income Tax
n/a 5.84M 197K -2.32M
Change in Working Capital
296K 1.06M 966K 895K
Operating Cash Flow
-14.89M -21.27M -16.11M -13.96M
Capital Expenditures
-18K -585K -271K -633K
Cash Acquisitions
n/a 47K 3.9M 592K
Purchase of Investments
-361K -1.59M -2.72M -22.54M
Sales Maturities Of Investments
5.72M 1.3M 10.08M 22.29M
Other Investing Acitivies
-631K -585K 11.07M -347K
Investing Cash Flow
4.71M -832K 10.99M -631K
Debt Repayment
2.25M n/a n/a -4.85M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.3M 485K n/a 13.04M
Financial Cash Flow
6.44M 485K 80K 8.19M
Net Cash Flow
-3.74M -21.61M -5.04M -6.41M
Free Cash Flow
-14.91M -21.85M -16.38M -14.6M